This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB07557/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07557/identifier/chemspider/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07557/identifier/chebi/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07557/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07557/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07557/identifier/pubchem-substance/

Statements

Subject Item
n2:DB07557
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB07557 n15:DB07557
dcterms:title
(5BETA)-PREGNANE-3,20-DIONE
adms:identifier
n9:92745 n10:99444028 n11:DB07557 n12:CI2 n13:30154 n14:83723
n3:IUPAC-Name
n4:271B5000-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5006-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5005-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5002-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5003-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5004-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4FFE-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4FFC-363D-11E5-9242-09173F13E4C5 n4:271B4FFF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4FFD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B500C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B500D-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5007-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5008-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B500A-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5009-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B500B-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5012-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5014-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5015-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5011-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5010-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5013-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5001-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B500E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B500F-363D-11E5-9242-09173F13E4C5